The FDA recommends that patients due to start treatment with Veopoz be vaccinated at least two weeks beforehand. The approval also puts Regeneron in line for a valuable priority review voucher ...
In a late-stage, head-to-head trial against Alexion Pharmaceuticals’ standard-of-care medicine Ultomiris, Regeneron showed that its combination of the antibody Veopoz with an investigative siRNA ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback